Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) EBT: 2010-2025

Historic EBT for Neogen (NEOG) over the last 16 years, with May 2025 value amounting to -$1.1 billion.

  • Neogen's EBT rose 380.66% to $43.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$1.1 billion, marking a year-over-year decrease of 3300.24%. This contributed to the annual value of -$1.1 billion for FY2025, which is 7821.08% down from last year.
  • Latest data reveals that Neogen reported EBT of -$1.1 billion as of FY2025, which was down 7,821.08% from -$14.3 million recorded in FY2024.
  • Over the past 5 years, Neogen's EBT peaked at $75.3 million during FY2021, and registered a low of -$1.1 billion during FY2025.
  • For the 3-year period, Neogen's EBT averaged around -$389.8 million, with its median value being -$22.0 million (2023).
  • As far as peak fluctuations go, Neogen's EBT soared by 35.10% in 2024, and later plummeted by 7,821.08% in 2025.
  • Neogen's EBT (Yearly) stood at $75.3 million in 2021, then declined by 20.01% to $60.2 million in 2022, then crashed by 136.61% to -$22.0 million in 2023, then spiked by 35.10% to -$14.3 million in 2024, then tumbled by 7,821.08% to -$1.1 billion in 2025.